{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:47:14Z","timestamp":1772830034677,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T00:00:00Z","timestamp":1508976000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s11060-017-2641-3","type":"journal-article","created":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T11:43:08Z","timestamp":1509018188000},"page":"173-180","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Influence of neutrophil\u2013lymphocyte ratio in prognosis of glioblastoma multiforme"],"prefix":"10.1007","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6178-701X","authenticated-orcid":false,"given":"Marta","family":"Lopes","sequence":"first","affiliation":[]},{"given":"Bruno","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Vaz","sequence":"additional","affiliation":[]},{"given":"Paulo","family":"Linhares","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,10,26]]},"reference":[{"key":"2641_CR1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674","journal-title":"Cell"},{"key":"2641_CR2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.semcancer.2013.02.001","volume":"23","author":"F Donskov","year":"2013","unstructured":"Donskov F (2013) Immunomonitoring and prognostic relevance of neutrophils in clinical trials. Semin Cancer Biol 23:200\u2013207","journal-title":"Semin Cancer Biol"},{"key":"2641_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju124","author":"AJ Templeton","year":"2014","unstructured":"Templeton AJ, McNamara MG, Seruga B et al (2014) Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. doi: 10.1093\/jnci\/dju124","journal-title":"J Natl Cancer Inst"},{"key":"2641_CR4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","volume":"88","author":"GJ Guthrie","year":"2013","unstructured":"Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ (2013) The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol 88:218\u2013230","journal-title":"Crit Rev Oncol Hematol"},{"key":"2641_CR5","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/cncr.26494","volume":"118","author":"AS Darefsky","year":"2012","unstructured":"Darefsky AS, King JT Jr., Dubrow R (2012) Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registries. Cancer 118:2163\u20132172","journal-title":"Cancer"},{"key":"2641_CR6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(07)70384-4","volume":"9","author":"T Gorlia","year":"2008","unstructured":"Gorlia T, van den Bent MJ, Hegi ME (2008) Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981 \u2013 22981\/CE.3. Lancet Oncol 9:29\u201338","journal-title":"Lancet Oncol"},{"key":"2641_CR7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1215\/S1152851703000620","volume":"6","author":"KR Lamborn","year":"2004","unstructured":"Lamborn KR, Chang SM, Prados MD (2004) Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol 6:227\u2013235","journal-title":"Neuro Oncol"},{"key":"2641_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12481","author":"B Fekete","year":"2015","unstructured":"Fekete B, Werlenius K, \u00d6rndal C, Rydenhag B (2015) Prognostic factors for glioblastoma patients\u2014A clinical population-based study. Acta Neurol Scand. doi: 10.1111\/ane.12481","journal-title":"Acta Neurol Scand"},{"key":"2641_CR9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11060-013-1164-9","volume":"114","author":"RM Bambury","year":"2013","unstructured":"Bambury RM, Teo MY, Power DG et al (2013) The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme. J Neurooncol 114:149\u2013154","journal-title":"J Neurooncol"},{"key":"2641_CR10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11060-014-1366-9","volume":"117","author":"MG McNamara","year":"2014","unstructured":"McNamara MG, Lwin Z, Jiang H et al (2014) Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil\/lymphocyte ratio and time to first progression. J Neurooncol 117:147\u2013152","journal-title":"J Neurooncol"},{"key":"2641_CR11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1186\/s12885-015-1629-7","volume":"15","author":"S Han","year":"2015","unstructured":"Han S, Liu Y, Li Q, Li Z, Hou H, Wu A (2015) Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma. BMC Cancer 15:617\u2013626","journal-title":"BMC Cancer"},{"key":"2641_CR12","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15235","author":"PF Wang","year":"2017","unstructured":"Wang PF, Song HW, Cai HQ et al (2017) Preoperative inflammation markers and IDH mutation status predict glioblastoma patient survival. Oncotarget. doi: 10.18632\/oncotarget.15235","journal-title":"Oncotarget"},{"key":"2641_CR13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11060-013-1240-1","volume":"115","author":"GA Alexiou","year":"2013","unstructured":"Alexiou GA, Vartholomatos E, Voulgaris S (2013) Prognostic value of neutrophil-to-lymphocyte ratio in patients with glioblastoma. J Neurooncol 115:521\u2013522","journal-title":"J Neurooncol"},{"key":"2641_CR14","doi-asserted-by":"crossref","first-page":"e395-e403","DOI":"10.1016\/S1470-2045(14)70011-7","volume":"15","author":"M Weller","year":"2014","unstructured":"Weller M, van den Bent M, Hopkins K et al (2014) EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. Lancet Oncol 15:e395-e403","journal-title":"Lancet Oncol"},{"key":"2641_CR15","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/neuonc\/not069","volume":"15","author":"CK Park","year":"2013","unstructured":"Park CK, Kim JH, Nam DH et al (2013) A practical scoring system to determine whether to proceed with surgical resection in recurrent glioblastoma. Neuro Oncol 15:1096\u20131101","journal-title":"Neuro Oncol"},{"key":"2641_CR16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/0022-3859.180551","volume":"62","author":"V Subeikshanan","year":"2016","unstructured":"Subeikshanan V, Dutt A, Basu D, Tejus MN, Maurya VP, Madhugiri VS (2016) A prospective comparative clinical study of peripheral blood counts and indices in patients with primary brain tumors. J Postgrad Med 62:86\u201390","journal-title":"J Postgrad Med"},{"key":"2641_CR17","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11726","author":"W Wang","year":"2016","unstructured":"Wang W, Zhang L, Wang Z et al (2016) A three-gene signature for prognosis in patients with MGMT promoter-methylated glioblastoma. Oncotarget. doi: 10.18632\/oncotarget.11726","journal-title":"Oncotarget"},{"key":"2641_CR18","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","volume":"321","author":"DW Parsons","year":"2008","unstructured":"Parsons DW, Jones S, Zhang X et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807\u20131812","journal-title":"Science"},{"key":"2641_CR19","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1200\/JCO.2009.21.9832","volume":"27","author":"M Sanson","year":"2009","unstructured":"Sanson M, Marie Y, Paris S et al (2009) Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol 27:4150\u20134154","journal-title":"J Clin Oncol"},{"key":"2641_CR20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.nec.2012.04.009","volume":"23","author":"W Kim","year":"2012","unstructured":"Kim W, Liau LM (2012) IDH mutations in human glioma. Neurosurg Clin N Am 23:471\u2013480","journal-title":"Neurosurg Clin N Am"},{"key":"2641_CR21","doi-asserted-by":"crossref","first-page":"e2583","DOI":"10.1097\/MD.0000000000002583","volume":"95","author":"JR Chen","year":"2016","unstructured":"Chen JR, Yao Y, Xu HZ, Qin ZY (2016) Isocitrate dehydrogenase (IDH)1\/2 mutations as prognostic markers in patients with glioblastomas. Medicine (Baltimore) 95:e2583","journal-title":"Medicine (Baltimore)"},{"key":"2641_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/540236","author":"XW Wang","year":"2014","unstructured":"Wang XW, Ciccarino P, Rossetto M et al (2014) IDH mutations: genotype-phenotype correlation and prognostic impact. Biomed Res Int. doi: 10.1155\/2014\/540236","journal-title":"Biomed Res Int"},{"key":"2641_CR23","doi-asserted-by":"crossref","first-page":"E1186-99","DOI":"10.1002\/humu.21201","volume":"31","author":"LA Gravendeel","year":"2010","unstructured":"Gravendeel LA, Kloosterhof NK, Bralten LB et al (2010) Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of glioma. Hum Mutat 31:E1186-99","journal-title":"Hum Mutat"},{"key":"2641_CR24","volume-title":"WHO classification of tumours of the central nervous system","author":"D Louis","year":"2016","unstructured":"Louis D, Ohgaki H, Wiestler O et al (2016) WHO classification of tumours of the central nervous system. WHO, Geneva"},{"key":"2641_CR25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2217\/fon.09.136","volume":"6","author":"CSD Roxburgh","year":"2010","unstructured":"Roxburgh CSD, McMillan DC (2010) Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 6:149\u2013163","journal-title":"Future Oncol"},{"key":"2641_CR26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s004010051093","volume":"98","author":"G Fossati","year":"1999","unstructured":"Fossati G, Ricevuti G, Edwards SW, Walker C, Dalton A (1999) Neutrophil infiltration into human gliomas. Acta Neuropathol 98:349\u2013354","journal-title":"Acta Neuropathol"},{"key":"2641_CR27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pjnns.2014.12.006","volume":"49","author":"P Zadora","year":"2015","unstructured":"Zadora P, Dabrowski W, Czarko K et al (2015) Preoperative neutrophil-lymphocyte count ratio helps predict the grade of glial tumor\u2014A pilot study. Neurol Neurochir Pol 49:41\u201344","journal-title":"Neurol Neurochir Pol"},{"key":"2641_CR28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1586\/erc.12.159","volume":"11","author":"T Bhat","year":"2013","unstructured":"Bhat T, Teli S, Rijal J et al (2013) Neutrophil to lymphocyte ratio and cardiovascular diseases\u2014A review. Expert Rev Cardiovasc Ther 11:55\u201359","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2641_CR29","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/jch.12533","volume":"17","author":"E Belen","year":"2015","unstructured":"Belen E, Sungur A, Sungur MA, Erdogan G (2015) Increased neutrophil to lymphocyte ratio in patients with resistant hypertension. J Clin Hypertens 17:532\u2013537","journal-title":"J Clin Hypertens"},{"key":"2641_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-015-0002-9","author":"M Lou","year":"2015","unstructured":"Lou M, Luo P, Tang R, Peng Y, Yu S, Huang W, He L (2015) Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients. BMC Endocr Disord. doi: 10.1186\/s12902-015-0002-9","journal-title":"BMC Endocr Disord"},{"key":"2641_CR31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.jrn.2011.10.020","volume":"22","author":"ND Vaziri","year":"2012","unstructured":"Vaziri ND, Pahl MV, Crum A, Norris K (2012) Effect of uremia on structure and function of immune system. J Ren Nutr 22:149\u2013156","journal-title":"J Ren Nutr"},{"key":"2641_CR32","first-page":"269","volume":"61","author":"H Fu","year":"2015","unstructured":"Fu H, Qin B, Hu Z, Ma N, Yang M, Wei T (2015) Neutrophil- and platelet-to-lymphocyte ratios are correlated with disease activity in rheumatoid arthritis. Clin Lab 61:269\u2013273","journal-title":"Clin Lab"},{"key":"2641_CR33","first-page":"11026","volume":"8","author":"L Li","year":"2015","unstructured":"Li L, Xia Y, Chen C, Cheng P, Peng C (2015) Neutrophil-lymphocyte ratio in systemic lupus erythematosus disease: a retrospective study. Int J Clin Exp Med 8:11026\u201311031","journal-title":"Int J Clin Exp Med"},{"key":"2641_CR34","volume-title":"Holland-Frei cancer medicine","author":"LI McKay","year":"2003","unstructured":"McKay LI, Cidlowski JA (2003) Physiologic and pharmacologic effects of corticosteroids. In: Kufe DW, Pollock RE, Weichselbaum RR et al (eds) Holland-Frei cancer medicine, 6th\u00a0edn. BC Decker, Hamilton","edition":"6"},{"key":"2641_CR35","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1016\/j.ejca.2011.03.028","volume":"47","author":"MJ Proctor","year":"2011","unstructured":"Proctor MJ, Morrison DS, Talwar D et al (2011) A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome study. Eur J Cancer 47:2633\u20132641","journal-title":"Eur J Cancer"},{"key":"2641_CR36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jpainsymman.2011.08.013","volume":"44","author":"M Partridge","year":"2012","unstructured":"Partridge M, Fallon M, Bray C, McMillan D, Brown D, Laird B (2012) Prognostication in advanced cancer\u2014A study examining an inflammation-based score. J Pain Symptom Manage 44:161\u2013167","journal-title":"J Pain Symptom Manage"},{"key":"2641_CR37","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ctrv.2012.08.003","volume":"39","author":"DC McMillan","year":"2013","unstructured":"McMillan DC (2013) The systemic inflammation-based Glasgow prognostic score: a decade of experience in patients with cancer. Cancer Treat Rev 39:534\u2013540","journal-title":"Cancer Treat Rev"},{"key":"2641_CR38","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2174\/187152011797378805","volume":"11","author":"RE Kast","year":"2011","unstructured":"Kast RE, Scheuerle A, Wirtz CR, Karpel-Massler G, Halatsch ME (2011) The rationale of targeting neutrophils with dapsone during glioblastoma treatment. Anticancer Agents Med Chem 11:756\u2013761","journal-title":"Anticancer Agents Med Chem"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-017-2641-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2641-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2641-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T02:06:45Z","timestamp":1570241205000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-017-2641-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,26]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["2641"],"URL":"https:\/\/doi.org\/10.1007\/s11060-017-2641-3","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,26]]}}}